Purchase Order 75N95021P00476

Award Date 8/26/21
Potential Completion Date 12/31/22
Potential Value $449K
Ultimate Awardee
Bruker Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $1,526,289.00 firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Bruker Biospin Corp, a for-profit manufacturer, to provide an AVANCE NEO 500 MHz wide-bore nuclear magnetic resonance (NMR) spectrometer and associated hardware and software. The contract was awarded on July 10, 2019 with a completion date of October 14, 2020. This award was not set aside for a specific business...
This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Bruker Biospin Corp. to provide annual service and maintenance for a Bruker Ascend 400 MHz nuclear magnetic resonance (NMR) spectrometer system with an Avance Neo Nanobay. The contract has a ceiling value of $68,484.50 and a period of performance through August 8, 2028. This award is not associated with any set-aside...
This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments and equipment. The $145,700.00 contract is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. The award has an ultimate completion date of May 31, 2019 and was not set aside for any...
This firm fixed-price purchase order for $22,695 awards Bruker Biospin Corporation the decommissioning and packing of a Bruker 400 MHz Avance NEO nuclear magnetic resonance (NMR) spectrometer and room temperature probe owned by the National Institutes of Health's National Center for Advancing Translational Sciences. As the sole source manufacturer of the proprietary NMR equipment, Bruker must perform the work to maintain warranty and ensure functionality of the components. The award is...
Bruker Biospin Corp. was awarded a $1 million firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to upgrade an existing 7 Tesla Magnetic Resonance Imaging Spectrometer and Console for continued biomedical research use. The upgrade is for a Bruker Biospec 7/30 scanner located at the agency's Neurophysiology Imaging Facility in Bethesda, Maryland, and is intended to maintain compatibility with existing...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $150,667.20 firm fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, for a service contract to maintain an Avance III/400 NMR spectrometer located in Baltimore, Maryland. This non-competitive acquisition is for commercial items and services, conducted under simplified acquisition procedures of the Federal Acquisition Regulation. The contract...
This is a federal contract award by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments and equipment. The contract, valued at $139,000.00, is for the purchase of Bruker's nuclear magnetic resonance (NMR) spectrometers, maintenance, and support services. The contract is a firm fixed price purchase order with a completion date of December 26, 2017. There...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $263,249.95 firm-fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, for the emergency evaluation and subsequent repair of a quenched 9.4T MRI scanner. The contract, which did not have a set-aside designation, was awarded on June 12, 2018, with a completion date of December 11, 2018. Bruker Biospin Corp is a subsidiary of Bruker...
This is a firm-fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Bruker Biospin Corp, a manufacturer of scientific instruments, on April 26, 2017. The contract, valued at $150,000.00, does not have a set-aside designation and is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. Bruker Biospin Corp is a manufacturer that provides specialized equipment and...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments and equipment. The $700,000.00 firm fixed-price purchase order was awarded on September 27, 2016 with a period of performance through June 30, 2017. The contract did not have a set-aside designation. Based on the vendor description, Bruker Biospin Corp has a history of providing nuclear magnetic resonance (NMR)...

This firm fixed-price purchase order for $448,560.63 was awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Bruker Biospin Corp. to deliver one 400 megahertz Nuclear Magnetic Resonance Spectrometer. The spectrometer will support the National Center for Advancing Translational Sciences and must be delivered within five months to the specified National Institutes of Health location in Rockville, Maryland. The original solicitation sought quotes for this analytical laboratory equipment to advance drug abuse research, with technical capability and past performance evaluated as more important than price. No subcontractors or set-aside designations were identified. The place of performance will be Billerica, Massachusetts and work must be completed by December 2022.

Generated 12/29/23, 3:16 PM